Class: Administration (73)
Intrapulmonary delivery of hematopoietic drug
Patent Number: 6012450This patent teaches the administration of hematopoietic stem cell stimulatory factors through the intrapulmonary route. This patent is interesting in light of the fact that exogenous stem cells generally go to the liver or lung.
Inventor: Rubsamen, Reid M. (Berkeley, CA)
Assignee: Aradigm Corporation (Hayward, CA)
Date of First Priority Issue: Tuesday March 5th, 1991
System and method for transplantation of cells
Patent Number: 5423778This patent teaches the expansion of stem cells and progeny of the stem cells in vivo in a patient. The patent discloses various chambers, as well as methods of introducing the cells into a patient so that the cells can be truly cultured "in vivo".
Inventors: Eriksson, Elof (Wellesley Hills, MA); Vogt, Peter M. (Newton, MA)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Thursday December 14th, 1989
Method of administering human pluripotent hematopoietic colony stimulating factor
Patent Number: 5662895This patent covers the hematopoietic uses of a tumor derived hematopoiesis stimulator called pluripotent colony stimulating factor...what is the modern name of this???
Inventors: Welte, Karl (New York, NY); Platzer, Erich (Spardorf, DE); Gabrilove, Janice L. (New York, NY); Mertelsmann, Roland (Mainz, DE); Moore, Malcolm A. S. (Larchmont, NY)
Assignee: Sloan-Kettering Institute (New York, NY)
Date of First Priority Issue: Thursday March 28th, 1985